Internal Medicine, Nephrology · Washington, DC
NPI
1528175114
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
730 24th St NW, Suite 17
Washington, DC, 20037
Phone (202) 337-7660
Groups this clinician bills Medicare through
Medicare paid, 2024
$293K
2,767 services
Medicare patients, 2024
677
Average age 75
Drug cost, 2024
$575K
2,133 prescriptions
Company payments, 2025
$499
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy A Marcus was code 99233 (hospital e&m - subsequent), 602 times for 193 patients. In total Jeremy A Marcus billed 2,767 services in 24 codes, and Medicare paid $293K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 602 | 193 | $99.68 | $60K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 591 | 316 | $13.88 | $8,203 |
| 99214 Office E&M - Established | Office | 483 | 291 | $77.17 | $37K |
| 90960 ESRD Related Services (not dialysis) | Office | 272 | 34 | $291.15 | $79K |
| 99215 Office E&M - Established | Office | 187 | 100 | $88.04 | $16K |
| 99223 Hospital E&M - Initial | Facility | 142 | 129 | $142.00 | $20K |
| 99232 Hospital E&M - Subsequent | Facility | 119 | 55 | $65.80 | $7,830 |
| 90966 ESRD Related Services (not dialysis) | Office | 82 | 11 | $251.33 | $21K |
| 99204 Office E&M - New | Office | 64 | 64 | $134.47 | $8,606 |
| 90961 ESRD Related Services (not dialysis) | Office | 60 | 23 | $241.93 | $15K |
| 99222 Hospital E&M - Initial | Facility | 30 | 30 | $110.98 | $3,329 |
| 99213 Office E&M - Established | Office | 23 | 22 | $69.58 | $1,600 |
| 99205 Office E&M - New | Office | 21 | 21 | $175.61 | $3,688 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 14 | 14 | $228.95 | $3,205 |
By year: 2022 $287K for 2,253 services; 2023 $289K for 2,246 services; 2024 $293K for 2,767 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy A Marcus prescribed most often to Medicare patients was Amlodipine Besylate, with 117 prescriptions and refills. In total Jeremy A Marcus wrote 2,133 Medicare prescriptions that cost $575K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 117 | 332 | 43 | $805 |
| Farxiga Dapagliflozin Propanediol | 108 | 254 | 27 | $134K |
| Jardiance Empagliflozin | 88 | 257 | 31 | $133K |
| Furosemide Generic | 85 | 226 | 29 | $782 |
| Allopurinol Generic | 81 | 218 | 24 | $796 |
| Chlorthalidone Generic | 79 | 235 | 30 | $2,142 |
| Losartan Potassium Generic | 79 | 223 | 24 | $928 |
| Carvedilol Generic | 69 | 197 | 25 | $666 |
| Atorvastatin Calcium Generic | 67 | 198 | 27 | $898 |
| Hydralazine Hcl Generic | 51 | 139 | 21 | $845 |
| Nifedipine Er Nifedipine | 45 | 134 | 12 | $1,842 |
| Prednisone Generic | 44 | 98 | 13 | $381 |
| Calcitriol Generic | 44 | 119 | 16 | $513 |
| Metoprolol Succinate Generic | 44 | 116 | 16 | $882 |
| Irbesartan Generic | 44 | 132 | 12 | $1,584 |
Brand drugs: 424 claims; generic drugs: 1,709 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy A Marcus $499 ($499 in general payments such as food, travel and fees) from 9 companies. The largest payer was Novartis Pharmaceuticals Corporation with $137.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $137 |
| Amgen Inc. AMGN | 4 | $93.9 |
| Vifor Pharma, Inc. | 3 | $73.36 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $50.13 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $43.44 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $31.2 |
| Novo Nordisk Inc NVO | 1 | $24.29 |
| Fresenius USA Marketing, Inc. | 1 | $24.2 |
| GlaxoSmithKline, LLC. GSK | 1 | $21.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.